Socioeconomic Disparities in Patients Undergoing Alcohol Septal Ablation for Hypertrophic Cardiomyopathy

接受酒精间隔消融术治疗肥厚型心肌病患者的社会经济差异

阅读:2

Abstract

BACKGROUND: Alcohol septal ablation (ASA) effectively treats select patients with hypertrophic obstructive cardiomyopathy (HOCM). Our study analyzes socioeconomic and geographic factors' influence on post-ASA outcomes to improve patient care and accessibility. METHODS: Using the National Inpatient Sample (2016-2021) and International Classification of Diseases 10th Revision codes, we identified patients with a primary diagnosis of HOCM who underwent ASA. Study populations were categorized into 3 groups based on the poverty income ratio. The primary outcome was in-hospital complications following the procedure. Secondary outcomes included length of stay, hospitalization costs, and disposition status. RESULTS: Of 8585 patients who underwent ASA, 45.3% were from low SES backgrounds. Medicare was the primary payer, with treatments predominantly occurring in urban teaching hospitals for elective procedures in the southern region. Low and middle-SES patients showed higher rates of in-hospital mortality, sudden cardiac arrest, and increased pacemaker placements compared to high-SES groups. They experienced more extended hospital stays, which was associated with higher hospitalization costs and more transfers to skilled nursing facilities than high SES patients (all P < .05). However, other complications, such as acute stroke and acute kidney injury, showed no significant differences among the groups. CONCLUSIONS: Lower and middle socioeconomic HOCM patients who underwent ASA face higher in-hospital mortality, more sudden cardiac arrests, increased pacemaker placements, and more extended hospital stays compared to higher socioeconomic patients, highlighting the need for standardized outcomes for all ASA patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。